Quantitative analysis of retinopathy in type 2 diabetes: identification of prognostic parameters for developing visual loss secondary to diabetic maculopathy
- PMID: 15606463
- DOI: 10.1111/j.1600-0420.2004.00364.x
Quantitative analysis of retinopathy in type 2 diabetes: identification of prognostic parameters for developing visual loss secondary to diabetic maculopathy
Abstract
Purpose: To describe whether quantitative assessment of early changes in the morphology of retinopathy lesions can predict development of vision-threatening diabetic maculopathy.
Methods: We used a nested case-control study, and we studied 11 type 2 diabetes patients who had developed visual loss secondary to diabetic maculopathy. For each diabetes patient, we also studied three matched control patients who had been followed for a comparable period of time without developing visual loss. Fundus photographs describing the early development of retinopathy were digitized and subjected to a full manual quantitative grading on a computer monitor. Differences in the early development of retinal morphology were compared between the two groups. The outcome parameters were changes in the number and area of haemorrhages and exudates in different regions of the fundus, and the weighted distance of these lesions from the fovea and the optic disc.
Results: In patients who developed visual loss secondary to diabetic maculopathy there was significant early progression in the total area and number of haemorrhages and exudates. The haemorrhages had progressed in all retinal areas except the area around the optic disc and the temporal vascular arcades. The exudates had progressed temporally from the fovea and in the retinal periphery.
Conclusions: The results suggest that a quantitative description of the regional development of early diabetic retinopathy may help in identifying patients who will later develop vision-threatening maculopathy.
Similar articles
-
Diabetic retinopathy progression and visual outcome after phacoemulsification in South-Asian and Afro-Caribbean patients with diabetes.Eye (Lond). 2004 Jun;18(6):575-9. doi: 10.1038/sj.eye.6700747. Eye (Lond). 2004. PMID: 14716320
-
Entoptic evaluation of diabetic retinopathy.Invest Ophthalmol Vis Sci. 1997 Apr;38(5):783-91. Invest Ophthalmol Vis Sci. 1997. PMID: 9112972
-
Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes.Ophthalmology. 2009 Oct;116(10):1949-59.e8. doi: 10.1016/j.ophtha.2009.06.066. Epub 2009 Aug 21. Ophthalmology. 2009. PMID: 19699533
-
Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes.Prog Retin Eye Res. 2005 May;24(3):355-77. doi: 10.1016/j.preteyeres.2004.07.004. Epub 2004 Dec 16. Prog Retin Eye Res. 2005. PMID: 15708833 Review.
-
Localized retinal morphology and differential light sensitivity in diabetic retinopathy. Methodology and clinical results.Acta Ophthalmol Suppl (1985). 1992;(207):1-36. Acta Ophthalmol Suppl (1985). 1992. PMID: 1486330 Review.
Cited by
-
A deep learning system for detecting diabetic retinopathy across the disease spectrum.Nat Commun. 2021 May 28;12(1):3242. doi: 10.1038/s41467-021-23458-5. Nat Commun. 2021. PMID: 34050158 Free PMC article.
-
Diameter Changes of Retinal Vessels in Diabetic Retinopathy.Curr Diab Rep. 2017 Aug 8;17(10):82. doi: 10.1007/s11892-017-0909-9. Curr Diab Rep. 2017. PMID: 28791532 Review.
-
Spatial distribution of early red lesions is a risk factor for development of vision-threatening diabetic retinopathy.Diabetologia. 2017 Dec;60(12):2361-2367. doi: 10.1007/s00125-017-4424-y. Epub 2017 Sep 7. Diabetologia. 2017. PMID: 28884200 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical